Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-3.94%
operating margin TTM
-3.84%
revenue TTM
50.29 Million
revenue per share TTM
3.62$
valuation ratios | |
|---|---|
| pe ratio | -37.92 |
| peg ratio | 0.28 |
| price to book ratio | 19.94 |
| price to sales ratio | 1.47 |
| enterprise value multiple | -92.33 |
| price fair value | 19.94 |
profitability ratios | |
|---|---|
| gross profit margin | 45.88% |
| operating profit margin | -3.84% |
| pretax profit margin | -4.14% |
| net profit margin | -3.94% |
| return on assets | -8.02% |
| return on equity | -57.99% |
| return on capital employed | -28.61% |
liquidity ratios | |
|---|---|
| current ratio | 0.98 |
| quick ratio | 0.98 |
| cash ratio | 0.34 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 76.01 |
| days of payables outstanding | 66.64 |
| cash conversion cycle | 9.37 |
| receivables turnover | 4.80 |
| payables turnover | 5.48 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.18 |
| debt equity ratio | 1.17 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.54 |
| interest coverage | 0.00 |
| cash flow to debt ratio | 0.88 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.27 |
| cash per share | 0.51 |
| operating cash flow per share | 0.32 |
| free cash flow operating cash flow ratio | 0.87 |
| cash flow coverage ratios | 0.88 |
| short term coverage ratios | 2.73 |
| capital expenditure coverage ratio | 7.60 |
Frequently Asked Questions
When was the last time Champions Oncology, Inc. (NASDAQ:CSBR) reported earnings?
Champions Oncology, Inc. (CSBR) published its most recent earnings results on 12-03-2026.
What is Champions Oncology, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Champions Oncology, Inc. (NASDAQ:CSBR)'s trailing twelve months ROE is -57.99%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Champions Oncology, Inc. (CSBR) currently has a ROA of -8.02%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CSBR's net profit margin stand at?
CSBR reported a profit margin of -3.94% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CSBR's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.98 in the most recent quarter. The quick ratio stood at 0.98, with a Debt/Eq ratio of 1.17.